Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 Next >
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Pharmaceuticals Business Europe Economy
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Health care industry Health & Science Social issues
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Walt Disney Co Ford Motor Co Technology
From CNBC.com News
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
Tags Hospitals Airbnb Inc AI Effect
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Walt Disney Co Stock markets PepsiCo Inc/
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Biotechnology Business News LILLY DRN
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Medicare Nutrition Health care industry
From CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Tags LILLY DRN Merck & Co Inc Business News
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags World economy Breaking News: Davos LILLY DRN
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags IQVIA Holdings Inc Novo Nordisk A/S Illumina Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags LILLY DRN Merck & Co Inc Business News
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Science Biotech and Pharmaceuticals Business
From CNBC.com News
Jim Cramer says he supports healthcare stocks for their long-term value
Tags Mad Money U/S/ Markets Markets
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Biotech and Pharmaceuticals Moderna Inc UnitedHealth Group Inc
From CNBC.com News
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
Tags Health care industry Business Health & Science
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Health care industry Business Health & Science
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Health care industry Pharmaceuticals Health & Science
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Bristol/Myers Squibb Co Health care industry Accolade Inc
From CNBC.com News
Cramer's Lightning Round: Uber is a buy
Tags Uber Technologies Inc Market Outlook Business News
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Biotechnology Business News LILLY DRN
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Companies Pharmaceuticals Health care industry
From CNBC.com News
5 things to know before the stock market opens Friday
Tags Technology Investing Markets
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
Tags Health care industry Companies Pharmaceuticals
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Health care industry Roche Holding AG Social issues
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Biotechnology Novo Nordisk A/S Business News
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Obesity Prescription drugs Cybersecurity
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Weight management
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Health & Science Business Science
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.